Trump expected to sign an order moving to reclassify cannabis and open up medical potential
Read Original Source
WASHINGTON — President Donald Trump is expected to sign an executive order as soon as this week that would fast-track the reclassification of cannabis and acknowledge its medical benefits for the first time at the federal level, four people with direct knowledge of the plans told NBC News. Limited time: Save 25% on NBC News subscription Get exclusive reporting, live Q&As and ad-free reading. Cannabis is classified in the same category as heroin and LSD under the Controlled Substances Act of 1970.
AI Summary
Main Idea: President Donald Trump is expected to sign an order that would move cannabis to a less restricted federal category and recognize its medical uses.
Key Points:
- The change would move cannabis from Schedule I to Schedule III, which would make research easier and reduce some regulatory barriers.
- The order would not make marijuana legal nationwide, but it would mark a major shift in federal policy.
- It would direct the Drug Enforcement Administration or Attorney General Pam Bondi to finish the rescheduling process and publish the final rule.
- The order could also push Congress to pass banking protections for legal cannabis businesses and may allow Medicare reimbursement for some CBD products.
Impact on the People
Negative Impact
Some people may see faster access to cannabis as risky because federal reclassification could expand use before the health effects are fully settled.
Positive Impact
Reclassification by the DEA or Attorney General Pam Bondi could make medical research easier, help patients access cannabis-based treatments, and support legal cannabis businesses with banking.
How did each entity affect people?
Rate how each entity in this article affected the American people.
- Primary:President Donald Trumpperson
- Major:
- Major:Drug Enforcement Administrationgovernment agency or body
Candidate Entities9 candidates · 5 weighted vote min · 70% decision
- President Donald TrumppersonPrimaryEvaluated
Central figure expected to sign the executive order and whose comments drive the story.
Include 0 (0%)Ignore 0 (0%)5 to threshold - Attorney General Pam BondipersonMajorEvaluated
Named official who may be directed to conclude the formal rescheduling process.
Include 0 (0%)Ignore 0 (0%)5 to threshold - Drug Enforcement Administrationgovernment agency or bodyMajorEvaluated
The article says its administrator may be directed to complete the cannabis rescheduling process.
Include 0 (0%)Ignore 0 (0%)5 to threshold - Food and Drug Administrationgovernment agency or bodyMajorAI selected
Central regulator whose role in studying cannabis for medical purposes is a major part of the story.
Include 0 (0%)Ignore 0 (0%)5 to threshold - Department of Health and Human Servicesgovernment agency or bodyContextCandidate
Mentioned as part of meetings shaping the administration’s cannabis policy.
Include 0 (0%)Ignore 0 (0%)5 to threshold - Dr. Marty MakarypersonContextCandidate
Named FDA commissioner included in discussions about the expected order.
Include 0 (0%)Ignore 0 (0%)5 to threshold - Dr. Mehmet OzpersonContextCandidate
Named CMS administrator involved in meetings about the cannabis-related order.
Include 0 (0%)Ignore 0 (0%)5 to threshold
Comments 0
Comments here are the same thread shown when this article appears in The Pulse.
No comments on this article yet.
Sign in to comment